CSL Limited (CMXHF) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning everyone and welcome to CSL's Financial Year 2024 results presentation. I'm Joy Linton, CSL's Chief Financial Officer, and before we begin the formalities today, I would like to say a few words about Mark Daring, who has opened these calls over the past 21 years. As many of you know, Mark Daring has decided to retire as the head of CSL's Investor Relations function. over his extensive time with us. He's been a trusted advisor to our leadership group and a respected spokesperson with the investment community. In the time I've been at CSL, I've very much valued Mark's wisdom, guidance and insights. So thank you, Mark. Also with us today, having moved into Mark's role, is Chris Cooper, who joined CSL earlier this year. Many of you will know Chris from his successful career as a healthcare analyst, and we are delighted to have him on our side of the fence. So Chris, welcome to your first CSL results announcement, and over to you. Thank you, Joy, and good morning, everyone. It's a pleasure to be here. I also want to personally thank Mark for his help and support while I've been at CSL, and particularly for all those years previously. I've met or spoken with many of you before, and I'm looking forward to doing so again in the days and weeks ahead. I'm pleased to be joined this morning by three of CSL's leadership team. With me are Dr. Paul McKenzie, CSL's Chief Executive Officer, Joy Linton, CSL's Chief Financial Officer, and Ken Lim, CSL's Chief Strategy Officer. As with past practice, Paul will provide an overview of the results, then Joy will provide some additional detail on the financials. We'll then move to Q&A. With a view to giving everyone an opportunity to ask a question, could you please limit your questions to two? If you do have a further question...